• nl

Carduso Capital portfolio company AGILeBiotics winner of the ‘Investors Forum Price’ on the Dutch Life Sciences conference in Leiden on November 28th 2019.

AGILeBiotics is passionately translating innovation into novel antibacterials to treat patients infected by life-threatening hospital-acquired multidrug-resistant bacteria.